Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had ...

A former commissioner of the Food and Drug Administration says its vital to invest in ensuring infant formula and breast milk banks are inspected rigorously.

RBC Capital analyst James Edwardes Jones maintained a Buy rating on Reckitt (RKT – Research Report) today and set a price target of £57.00. The ...

J.P. Morgan analyst Celine Pannuti CFA maintained a Hold rating on Reckitt (RKT – Research Report) today. The company’s shares closed yesterday ...

As today's potential customers continue to seek mindfulness and stress relief, there is no better time to elevate their user ...

Reckitt faces potential tariff issues in the U.S. due to its manufacturing reliance on imports from Mexico and Southeast Asia ...